0001567619-20-000438.txt : 20200103 0001567619-20-000438.hdr.sgml : 20200103 20200103215343 ACCESSION NUMBER: 0001567619-20-000438 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191224 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DENNER ALEXANDER J CENTRAL INDEX KEY: 0001361754 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 20507954 MAIL ADDRESS: STREET 1: C/O SARISSA CAPITAL MANAGEMENT LP STREET 2: 660 STEAMBOAT ROAD, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 FORMER NAME: FORMER CONFORMED NAME: Denner Alexander J DATE OF NAME CHANGE: 20060504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sarissa Capital Management LP CENTRAL INDEX KEY: 0001577524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 20507955 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sarissa Capital Offshore Master Fund LP CENTRAL INDEX KEY: 0001577530 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 20507956 BUSINESS ADDRESS: STREET 1: C/O SARISSA CAPITAL MANAGEMENT STREET 2: 660 STEAMBOAT ROAD 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: C/O SARISSA CAPITAL MANAGEMENT STREET 2: 660 STEAMBOAT ROAD 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sarissa Capital Catapult Fund LLC CENTRAL INDEX KEY: 0001716725 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 20507957 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sarissa Capital Hawkeye Fund LP CENTRAL INDEX KEY: 0001777184 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 20507958 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203 302 2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc1.xml FORM 4 X0306 4 2019-12-24 0 0001505512 Regulus Therapeutics Inc. RGLS 0001361754 DENNER ALEXANDER J C/O SARISSA CAPITAL MANAGEMENT LP 660 STEAMBOAT ROAD GREENWICH CT 06830 0 0 1 0 0001577524 Sarissa Capital Management LP 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830 0 0 1 0 0001577530 Sarissa Capital Offshore Master Fund LP C/O SARISSA CAPITAL MANAGEMENT 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830 0 0 1 0 0001716725 Sarissa Capital Catapult Fund LLC C/O SARISSA CAPITAL MANAGEMENT LP 660 STEAMBOAT ROAD, 3RD FLOOR GREENWICH CT 06830 0 0 1 0 0001777184 Sarissa Capital Hawkeye Fund LP C/O SARISSA CAPITAL MANAGEMENT LP 660 STEAMBOAT ROAD, 3RD FLOOR GREENWICH CT 06830 0 0 1 0 Class A-2 Convertible Preferred Stock 0.666 2019-12-24 2019-12-24 4 P 0 423162 A Common Stock 4231620 423162 I See Footnotes Warrants to Purchase Common Stock 6.66 2019-12-24 2019-12-24 4 P 0 4231620 A 2019-12-24 2024-12-24 Common Stock 4231620 6083471 I See Footnotes See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. Explanation of Responses - Exhibit 99.1 SARISSA CAPITAL MANAGEMENT LP; By: /s/ Mark DiPaolo, Senior Partner, General Counsel 2020-01-03 SARISSA CAPITAL OFFSHORE MASTER FUND LP; By: /s/ Mark DiPaolo, Authorized Person 2020-01-03 SARISSA CAPITAL CATAPULT FUND LLC; By: /s/ Mark DiPaolo, Senior Partner, General Counsel 2020-01-03 SARISSA CAPITAL HAWKEYE FUND LP; By: /s/ Mark DiPaolo, Authorized Person 2020-01-03 /s/ Alexander Denner 2020-01-03 EX-99.1 2 d32683160.htm EXPLANATION OF RESPONSES
Explanation of Responses

(1)
Pursuant to a securities purchase agreement, dated as of May 3, 2019 (the “Purchase Agreement”), by and among Regulus Therapeutics Inc. (the “Issuer”), Sarissa Capital Offshore Master Fund LP, a Cayman Islands exempted limited partnership (“Sarissa Offshore”), Sarissa Capital Catapult Fund LLC, a Delaware limited liability company (“Sarissa Catapult”), and Sarissa Capital Hawkeye Fund LP, a Delaware limited partnership (“Sarissa Hawkeye” and, collectively with Sarissa Offshore and Sarissa Catapult, the “Sarissa Funds”), and the other investors identified therein, on December 24, 2019, at a “milestone closing” (the “Milestone Closing”), the Sarissa Funds purchased, in the aggregate, 423,162 shares of non-voting series A-2 convertible preferred stock of the Issuer, par value $0.001 per share (the “A-2 Preferred Shares”), and accompanying warrants to purchase 4,231,620 shares of common stock, par value $0.001 per share (the “Common Stock”), for aggregate consideration of approximately $3.35 million.  Each A-2 Preferred Share is convertible into 10 Shares, subject to certain beneficial ownership conversion limitations set forth in the Certificate of Designation of Preferences, Rights and Limitations of Class A-2 Convertible Preferred Stock of the Issuer.  Pursuant to the Purchase Agreement, the Sarissa Funds previously purchased, in the aggregate, 1,851,851 shares of Common Stock and warrants to purchase 1,851,851 shares of Common Stock.

(2)
Sarissa Capital Management LP, a Delaware limited partnership (“Sarissa Capital”), as the investment advisor to the Sarissa Funds, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the A-2 Preferred Shares and the warrants held directly by the Sarissa Funds.  By virtue of his position as the Chief Investment Officer of Sarissa Capital and by virtue of his control of the ultimate general partner of each of Sarissa Capital, Sarissa Offshore and Sarissa Hawkeye and of the managing member of Sarissa Catapult, Dr. Alexander Denner, a citizen of the United States of America, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the A-2 Preferred Shares and warrants directly held by the Sarissa Funds.

(3)
Each of Dr. Denner, Sarissa Capital, Sarissa Offshore, Sarissa Catapult and Sarissa Hawkeye disclaims beneficial ownership of the A-2 Preferred Shares and warrants except, in each case, to the extent of their pecuniary interest therein.